ketoconazole and buprenorphine

ketoconazole has been researched along with buprenorphine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Edwards, DJ; Ibrahim, RB; Thorsby, ME; Wilson, JG	1
Cipriano, A; Colucci, SV; Harris, SC; Kapil, RP; Michels, GH; Noveck, RJ; O'Keefe, SA; Perrino, P; Shet, MS	1
Gobburu, JVS; Liu, T	1

Trials

1 trial(s) available for ketoconazole and buprenorphine

Article	Year
Effect of ketoconazole on the pharmacokinetic profile of buprenorphine following administration of a once-weekly buprenorphine transdermal system. Clinical drug investigation, 2012, Sep-01, Volume: 32, Issue:9 Topics: Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Breath Tests; Buprenorphine; Cross-Over Studies; Double-Blind Method; Humans; Ketoconazole; Middle Aged; Placebos; Young Adult	2012

Article

Year

Effect of ketoconazole on the pharmacokinetic profile of buprenorphine following administration of a once-weekly buprenorphine transdermal system.

Clinical drug investigation, 2012, Sep-01, Volume: 32, Issue:9

Topics: Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Breath Tests; Buprenorphine; Cross-Over Studies; Double-Blind Method; Humans; Ketoconazole; Middle Aged; Placebos; Young Adult

2012

Other Studies

2 other study(ies) available for ketoconazole and buprenorphine

Article	Year
Effect of buprenorphine on CYP3A activity in rat and human liver microsomes. Life sciences, 2000, Feb-25, Volume: 66, Issue:14 Topics: Animals; Antineoplastic Agents, Hormonal; Aryl Hydrocarbon Hydroxylases; Buprenorphine; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dexamethasone; Enzyme Inhibitors; Humans; Hydroxytestosterones; In Vitro Techniques; Ketoconazole; Male; Microsomes, Liver; Narcotics; Oxidoreductases, N-Demethylating; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet	2000
A Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions of Buprenorphine After Subcutaneous Administration of CAM2038 With Perpetrators of CYP3A4. Journal of pharmaceutical sciences, 2018, Volume: 107, Issue:3 Topics: Administration, Cutaneous; Administration, Sublingual; Buprenorphine; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Ketoconazole; Rifampin	2018

Article

Year

Effect of buprenorphine on CYP3A activity in rat and human liver microsomes.

Life sciences, 2000, Feb-25, Volume: 66, Issue:14

Topics: Animals; Antineoplastic Agents, Hormonal; Aryl Hydrocarbon Hydroxylases; Buprenorphine; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dexamethasone; Enzyme Inhibitors; Humans; Hydroxytestosterones; In Vitro Techniques; Ketoconazole; Male; Microsomes, Liver; Narcotics; Oxidoreductases, N-Demethylating; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet

2000

A Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions of Buprenorphine After Subcutaneous Administration of CAM2038 With Perpetrators of CYP3A4.

Journal of pharmaceutical sciences, 2018, Volume: 107, Issue:3

Topics: Administration, Cutaneous; Administration, Sublingual; Buprenorphine; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Ketoconazole; Rifampin

2018